Nanobacterium
Nanobacteria are claimed to be cell-walled microorganisms with a diameter well below the generally accepted lower limit (about 0.2 micrometres) for bacteria.
Claims of their being living organisms are controversial. If they are living, there is speculation that they may be a new form of life, rather than bacteria.
| Table of contents |
|
2 1998 claims 3 April 2004 claims 4 May 2004 claims 5 See also 6 External links |
1996 Martian meteorite claims
Structures in the Martian meteorite ALH84001 have been interpreted by some as fossilized nanobacteria, but the origin of the structures is disputed.
1998 claims
Nanobacterium sanguineum was proposed in 1998 as an explanation of certain kinds of pathologic calcification (apatite in kidney stones) by Finnish researcher Olavi Kajander and Turkish researcher Neva Ciftcioglu, working at the University of Kuopio in Finland. According to the researchers the particles self-replicated in culture, and claimed to have identified a DNA sequence.
Further studies by another group reached different results, suggesting peculiar yet inanimate etiology of the disease.
A paper published in 2000 by a team lead by John Cisar of the US National Institutes of Health proposed that the "self-replication" was, infact, an unusual form of crystaline growth, and that contamination may have been the source of the DNA.
The fact that the Finnish group have set up a company (Nanobac Life Sciences, Inc., in Florida) to sell kits for the identification of nanobacteria, and is developing treatments for the supposedly associated diseases, has also raised doubts concerning their impartiality.
April 2004 claims
In a press release from Nanobac Life Sciences, Inc., claims that a strong correlation has been found between antibodies to nanobacteria and coronary artery calcification (associated with increased risk of coronary artery disease). The results were obtained using a testing kit produced by Nanobac, and tests on 198 patients that were lead by Stephen Epstein, Director of the Cardiovascular Research Institute, Washington Hospital Center, Washington.
May 2004 claims
In 2004 a team lead by Dr. John Lieske of the Mayo Clinic in Minnesota claimed to have discovered nanobacteria in diseased human arteries. Their results were accepted by the American Journal of Physiology - Heart and Circulatory Physiology, Virginia M. Miller et al., in May 2004 after extensive revision.
Unlike the Finnish researchers, those at the Mayo Clinic apparently have no linked commercial interests. Working with particles less than 0.2 micrometres in size, they found indirect evidence that the particles had self-replicated, and found that they had a cell-like appearance under an electron microscope. They also believe that the particles are producing RNA, since they absorbed one of its building blocks, uridine, in greater quantities than would be expected in the case of pure absorption (by crystals such as apatite). Using an antibody produced by the Finnish researchers, the particles were found to bind to diseased arterial tissue, and to the same sites to which a DNA stain bound. The researchers now hope to isolate RNA and DNA from the particles.
See also
External links